Health insurance plans prohibited from certain conditions for metastatic cancer patients; delete repealer.

SB 2367 prohibits health insurance plans in Mississippi from requiring metastatic cancer patients to fail or prove failure on other drugs before accessing FDA-approved treatments for advanced cancer. It directly affects patients with advanced, metastatic cancer and their insurers by eliminating step therapy barriers for covered prescription drugs. The law applies only to drugs consistent with medical best practices, supported by evidence-based research, and approved by the FDA. This change ensures patients can receive necessary treatments without unnecessary delays imposed by prior authorization requirements.